--2024/Q4-- / 596.820M--
Nov 6, 20242024/Q3565.000M / 731.832M--
Aug 8, 20242024/Q2537.000M / 645.290M--
May 9, 20242024/Q1568.000M / 709.445M--
Feb 15, 20242023/Q4596.000M / 674.541M--
US Stock MarketDetailed Quotes
RPRX Royalty Pharma
- 26.380
- +0.160+0.61%
Trading Nov 21 15:58 ET
11.72BMarket Cap10.39P/E (TTM)
26.660High26.230Low2.60MVolume26.260Open26.220Pre Close68.90MTurnover0.67%Turnover Ratio10.43P/E (Static)444.30MShares30.92252wk High1.71P/B10.23BFloat Cap24.80152wk Low0.83Dividend TTM387.82MShs Float51.220Historical High3.15%Div YieldTTM1.64%Amplitude24.801Historical Low26.490Avg Price1Lot Size
Royalty Pharma Key Stats
Royalty Pharma Q3 2024 Earnings Date
Currency：USDNov 6, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 731.83M | 564.69M | -167.14M |
| Miss Est. | +36.46% | +5.29% | -22.84% |
| EPS | 0 | 1.21 | +1.21 |
| Beat Est. | -- | +656.25% | -- |
Analyst Rating
Nov 19, 2024
Royalty Pharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Royalty Pharma Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data